RDHL - Redhill Biopharma Ltd.
Earnings Results
Results > 2019 > RDHL

Redhill Biopharma Ltd. ( RDHL )

Recent earnings result

  1. RedHill EPS beats by $0.21, misses on revenue

Top Stories (RDHL)

Events & Annual meetings

There are no events at this time for this stock.

For list of RDHL events, you may visit their Investor Relations website.

For more information you may also visit their official Investor Relations website.

RedHill Biopharma Ltd. (NASDAQ: RDHL) (Tel-Aviv Stock Exchange: RDHL) is a specialty biopharmaceutical company primarily focused on development and commercialization of proprietary drugs for the treatment of gastrointestinal diseases.

Recent results

Books we are reading